source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Synpromics and Adverum Biotechnologies expand research collaboration

Gene control specialist company Synpromics and Adverum Biotechnologies have expanded their research collaboration which began in December 2015. Their initial collaboration focused on using Synpromics technology to develop promoters for the treatment of eye diseases and has produced promising early…

Axiogenesis and Metrion Biosciences form stem cell collaboration

Axiogenesis AG, a preclinical biotechnology company specialising in the development and production of induced pluripotent stem cell (iPSC)-derived cells and tissues for preclinical applications, and Metrion Biosciences Ltd, a specialist ion channel CRO, have signed a collaboration agreement to validate,…

Domainex relocates to Chesterford Research Park

Domainex, a privately-owned drug research company established in 2001 and specialising in the expression of disease target proteins, hit discovery, hit-to-lead identification and lead optimisation, has relocated to Chesterford Research Park, Saffron Walden, UK. The company has achieved a reputation…

One Nucleus wins two global health and pharma awards

One Nucleus has won two international peer-nominated and peer-reviewed awards in the life science and health care sector. Global Health & Pharma magazine’s judging committee decided that One Nucleus should receive its Best Global Life Sciences Membership Organisation 2016 award…

CRT extends cancer drug alliance with Merck Group

Cancer Research Technology (CRT) has signed a further deal with German science and technology company Merck Group to discover new cancer drugs targeting the Hippo pathway. The extension to this alliance follows a successful one-year target validation and drug discovery…
Subscribe to this RSS feed